164 related articles for article (PubMed ID: 29775732)
1. IL4-10 fusion protein has chondroprotective, anti-inflammatory and potentially analgesic effects in the treatment of osteoarthritis.
Steen-Louws C; Popov-Celeketic J; Mastbergen SC; Coeleveld K; Hack CE; Eijkelkamp N; Tryfonidou M; Spruijt S; van Roon JAG; Lafeber FPJG
Osteoarthritis Cartilage; 2018 Aug; 26(8):1127-1135. PubMed ID: 29775732
[TBL] [Abstract][Full Text] [Related]
2. Canine IL4-10 fusion protein provides disease modifying activity in a canine model of OA; an exploratory study.
van Helvoort EM; Popov-Celeketic J; Eijkelkamp N; Coeleveld K; Tryfonidou MA; Wijne CD; Hack CE; Lafeber FPJG; Mastbergen SC
PLoS One; 2019; 14(7):e0219587. PubMed ID: 31295306
[TBL] [Abstract][Full Text] [Related]
3. Chondroprotective and anti-inflammatory effects of S-methylisothiourea, an inducible nitric oxide synthase inhibitor in cartilage and synovial explants model of osteoarthritis.
Balaganur V; Pathak NN; Lingaraju MC; More AS; Latief N; Kumari RR; Kumar D; Tandan SK
J Pharm Pharmacol; 2014 Jul; 66(7):1021-31. PubMed ID: 24697299
[TBL] [Abstract][Full Text] [Related]
4. IL4-10 fusion protein: a novel immunoregulatory drug combining activities of interleukin 4 and interleukin 10.
Steen-Louws C; Hartgring SAY; Popov-Celeketic J; Lopes AP; de Smet MBM; Eijkelkamp N; Lafeber FPJG; Hack CE; van Roon JAG
Clin Exp Immunol; 2019 Jan; 195(1):1-9. PubMed ID: 30307604
[TBL] [Abstract][Full Text] [Related]
5. IL4-10 Fusion Protein Is a Novel Drug to Treat Persistent Inflammatory Pain.
Eijkelkamp N; Steen-Louws C; Hartgring SA; Willemen HL; Prado J; Lafeber FP; Heijnen CJ; Hack CE; van Roon JA; Kavelaars A
J Neurosci; 2016 Jul; 36(28):7353-63. PubMed ID: 27413147
[TBL] [Abstract][Full Text] [Related]
6. A fusion protein of interleukin-4 and interleukin-10 protects against blood-induced cartilage damage in vitro and in vivo.
van Vulpen LFD; Popov-Celeketic J; van Meegeren MER; Coeleveld K; van Laar JM; Hack CE; Schutgens REG; Mastbergen SC; Lafeber FPJG
J Thromb Haemost; 2017 Sep; 15(9):1788-1798. PubMed ID: 28696534
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of COX-2 by celecoxib in the canine groove model of osteoarthritis.
Mastbergen SC; Marijnissen AC; Vianen ME; Zoer B; van Roermund PM; Bijlsma JW; Lafeber FP
Rheumatology (Oxford); 2006 Apr; 45(4):405-13. PubMed ID: 16287921
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of NSAIDs on joint destruction in osteoarthritis.
Rainsford KD
Agents Actions Suppl; 1993; 44():39-43. PubMed ID: 8372733
[TBL] [Abstract][Full Text] [Related]
9. The chondroprotective effect of selective COX-2 inhibition in osteoarthritis: ex vivo evaluation of human cartilage tissue after in vivo treatment.
de Boer TN; Huisman AM; Polak AA; Niehoff AG; van Rinsum AC; Saris D; Bijlsma JW; Lafeber FJ; Mastbergen SC
Osteoarthritis Cartilage; 2009 Apr; 17(4):482-8. PubMed ID: 18926729
[TBL] [Abstract][Full Text] [Related]
10. Acute synovitis and intra-articular methylprednisolone acetate in ponies.
Todhunter RJ; Fubini SL; Vernier-Singer M; Wootton JA; Lust G; Freeman KP; MacLeod JN
Osteoarthritis Cartilage; 1998 Mar; 6(2):94-105. PubMed ID: 9692064
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-4 and interleukin-10 are chondroprotective and decrease mononuclear cell recruitment in human rheumatoid synovium in vivo.
Jorgensen C; Apparailly F; Couret I; Canovas F; Jacquet C; Sany J
Immunology; 1998 Apr; 93(4):518-23. PubMed ID: 9659224
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of butanol fraction from Betula platyphyla var. japonica on cartilage alterations in a rabbit collagenase-induced osteoarthritis.
Huh JE; Baek YH; Kim YJ; Lee JD; Choi DY; Park DS
J Ethnopharmacol; 2009 Jun; 123(3):515-21. PubMed ID: 18817862
[TBL] [Abstract][Full Text] [Related]
13. The mechanism of action of nonsteroidal antiinflammatory drugs.
Brandt KD
J Rheumatol Suppl; 1991 Feb; 27():120-1. PubMed ID: 2027109
[TBL] [Abstract][Full Text] [Related]
14. Effects of SKI 306X, a new herbal agent, on proteoglycan degradation in cartilage explant culture and collagenase-induced rabbit osteoarthritis model.
Choi JH; Choi JH; Kim DY; Yoon JH; Youn HY; Yi JB; Rhee HI; Ryu KH; Jung K; Han CK; Kwak WJ; Cho YB
Osteoarthritis Cartilage; 2002 Jun; 10(6):471-8. PubMed ID: 12056850
[TBL] [Abstract][Full Text] [Related]
15. Selective COX-2 inhibition is favorable to human early and late-stage osteoarthritic cartilage: a human in vitro study.
Mastbergen SC; Bijlsma JW; Lafeber FP
Osteoarthritis Cartilage; 2005 Jun; 13(6):519-26. PubMed ID: 15922186
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological effects of novel cross-linked hyaluronate, Gel-200, in experimental animal models of osteoarthritis and human cell lines.
Yoshioka K; Yasuda Y; Kisukeda T; Nodera R; Tanaka Y; Miyamoto K
Osteoarthritis Cartilage; 2014 Jun; 22(6):879-87. PubMed ID: 24792209
[TBL] [Abstract][Full Text] [Related]
17. Down regulation of interleukin 1beta production in human osteoarthritic synovial tissue and cartilage cultures by aminoguanidine.
Shirazi I; Yaron I; Wollman Y; Blum M; Chernihovsky T; Judovich R; Iaina A; Yaron M
Ann Rheum Dis; 2001 Apr; 60(4):391-4. PubMed ID: 11247871
[TBL] [Abstract][Full Text] [Related]
18. Effects of the NSAIDs meloxicam and indomethacin on cartilage proteoglycan synthesis and joint responses to calcium pyrophosphate crystals in dogs.
Rainsford KD; Skerry TM; Chindemi P; Delaney K
Vet Res Commun; 1999 Mar; 23(2):101-13. PubMed ID: 10359154
[TBL] [Abstract][Full Text] [Related]
19. TNF‑α increases inflammatory factor expression in synovial fibroblasts through the toll‑like receptor‑3‑mediated ERK/AKT signaling pathway in a mouse model of rheumatoid arthritis.
Yu FY; Xie CQ; Jiang CL; Sun JT; Huang XW
Mol Med Rep; 2018 Jun; 17(6):8475-8483. PubMed ID: 29693122
[TBL] [Abstract][Full Text] [Related]
20. Nonsteroidal antiinflammatory drugs in treatment of osteoarthritis.
Brandt KD; Slowman-Kovacs S
Clin Orthop Relat Res; 1986 Dec; (213):84-91. PubMed ID: 3780106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
